These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35852930)

  • 1. Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions.
    Sayyid RK; Hiffa A; Woodruff P; Oberle MD; Lambert JH; Terris MK; Wallis CJD; Klaassen Z
    Cancer Invest; 2022 Oct; 40(9):743-749. PubMed ID: 35852930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov.
    Sacks CA; North CM; Wolf M; Dougan M; Campbell KR; Moggridge J; Fralick M
    J Gen Intern Med; 2022 Jan; 37(1):154-161. PubMed ID: 34755268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on otolaryngology research: a cross-sectional analysis of discontinued trials.
    Rucker BM; Sajjadi NB; Brame LS; Vassar M; Hartwell ML
    J Osteopath Med; 2022 Apr; 122(8):393-399. PubMed ID: 35363445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic.
    Villanueva G; Sampor C; Palma J; Villarroel M; Valencia D; Lombardi MG; Garcia WG; Caceres EL; Sobrero V; Garcia L; Cabrera V; Maza I; Velasquez T; Ugaz C; Vasquez JM; Coronado RD; Gonzalez N; Aguiar S; Dabezies A; Moreno F; Sardinas S; Gamboa Y; Maradiegue E; Fu L; Gassant P; Moreno K; Gonzales O; Schelotto M; Luna-Fineman S; Antoneli CG; Fuentes-Alabi S; Luciani S; Cappellano A; Chantada G; Vasquez L
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29748. PubMed ID: 35593012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov.
    Sakamaki K; Uemura Y; Shimizu Y
    Trials; 2021 Nov; 22(1):788. PubMed ID: 34749761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
    Wu H; Dai R; He P; Liang J; Li Q; Yang J; Lu H; Guo Q; Mao W; Ji C
    Int J Infect Dis; 2022 Mar; 116():210-215. PubMed ID: 35017106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies.
    Deng J; Lukens JN; Cohn JC; McMenamin E; Murphy B; Spinelli BA; Murphy N; Steinmetz AK; Landriau MA; Lin A
    Trials; 2022 Nov; 23(1):927. PubMed ID: 36348346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
    Gianola S; Jesus TS; Bargeri S; Castellini G
    PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
    Varshney AS; Wang DE; Bhatt AS; Blood A; Sharkawi MA; Siddiqi HK; Vaduganathan M; Monteleone PP; Patel MR; Jones WS; Lopes RD; Mehra MR; Bhatt DL; Kochar A
    Am Heart J; 2021 Feb; 232():105-115. PubMed ID: 33121978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials.
    Zhao MZ; Zhao C; Tu SS; Wei XX; Shang HC
    J Integr Med; 2021 Jul; 19(4):317-326. PubMed ID: 33789839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
    Bayle A; Baldini C; Martin-Romano P; Michot JM; Champiat S; Bahleda R; Gazzah A; Marabelle A; Verlingue L; Geraud A; Morel D; Michiels S; Hollebecque A; Albiges L; Besse B; Soria JC; Massard C; Barlesi F; Postel-Vinay S
    Cancer Cell; 2021 Aug; 39(8):1039-1041. PubMed ID: 34197735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.